ArticleOncotarget2019

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients.

Maria Bach Laursen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.